Legal estimation of adverse effects of genome technologies applied to embryos

Abstract

By manipulating the genome, it is possible to correct hereditary diseases in humans. Ensuring the birth of healthy children by diagnosing and selecting, for in vitro fertilization, an embryo that does not contain a pathogenic mutation is a serious prospect in modern genomic research. However, the legislative approaches of states towards this issue remain very ambiguous due to the complexity of the ethical and legal sides of this problem. We believe that a single consensus international position should be adopted on the issues of intervention in the human genome, otherwise permission to conduct in one country may lead to negative reactions in other states and lay criminal risks in this area.